Amicus Therapeutics (FOLD) Stock After Hours Dec. 19, 2025: BioMarin’s $14.50 Cash Buyout and What to Know Before the Next Market Open
Amicus Therapeutics, Inc. (NASDAQ: FOLD) ended Friday’s session (December 19, 2025) in a very different place than it started: the stock re-priced into “deal mode” after BioMarin Pharmaceutical (NASDAQ: BMRN) announced a definitive agreement to acquire Amicus in an all-cash